Latest Commercialisation Strategy News

Page 5 of 8
Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.
Ada Torres
Ada Torres
25 July 2025
Sunshine Metals has launched an advanced scoping study targeting 95,000 ounces of gold and 652,000 ounces of silver at its Liontown project in North Queensland. The study aims to optimise extraction from multiple high-grade resource domains, with metallurgical test results expected in August 2025.
Maxwell Dee
Maxwell Dee
23 July 2025
Amaero Ltd reports solid June quarter revenue and signs a pivotal five-year exclusive supply agreement with Velo3D, underpinning its growth outlook and updated EBITDA guidance for FY2027.
Victor Sage
Victor Sage
21 July 2025
Metallium Ltd has completed a A$50 million institutional raise, secured a Texas site, and validated its commercial Flash Joule Heating reactor, setting the stage for its first U.S. metals recovery plant commissioning by year-end 2025.
Maxwell Dee
Maxwell Dee
17 July 2025
ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.
Ada Torres
Ada Torres
16 July 2025
Archer Materials advances its quantum computing and medical diagnostics technologies, extending key partnerships and forming a new advisory board while maintaining a strong cash position to fuel development.
Sophie Babbage
Sophie Babbage
14 July 2025
InteliCare has launched a three-month trial of its AI-powered platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy with a leading aged care provider.
Ada Torres
Ada Torres
11 July 2025
Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.
Ada Torres
Ada Torres
10 July 2025
Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.
Ada Torres
Ada Torres
1 July 2025
First Graphene Limited has secured two significant orders totaling approximately A$165,000 for its PureGRAPH graphene products, signaling growing market acceptance and supporting its FY25-26 sales outlook.
Maxwell Dee
Maxwell Dee
1 July 2025
Astral Resources has released a compelling Pre-Feasibility Study for its Mandilla Gold Project in Western Australia, outlining a 19-year mine life with robust economics and a maiden ore reserve of 1.1 million ounces. The study sets the stage for a Definitive Feasibility Study targeted for mid-2026.
Maxwell Dee
Maxwell Dee
25 June 2025
Rhythm Biosciences has regained NATA accreditation for its geneType laboratory, a key step toward commercialising its ColoSTAT® cancer risk test as an in-house diagnostic.
Ada Torres
Ada Torres
24 June 2025